These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7877502)

  • 1. Rapid determination of cellular resistance-related drug efflux in tumor cells.
    Krishan A
    Methods Cell Biol; 1994; 42 Pt B():21-30. PubMed ID: 7877502
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid determination of cellular resistance-related drug efflux in tumor cells.
    Krishan A
    Methods Cell Biol; 1990; 33():491-500. PubMed ID: 2084481
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring of cellular resistance to cancer chemotherapy: drug retention and efflux.
    Krishan A
    Methods Cell Biol; 2001; 64():193-209. PubMed ID: 11070840
    [No Abstract]   [Full Text] [Related]  

  • 4. Apoptosis induced by doxorubicin and cinchonine in P388 multidrug-resistant cells.
    Furusawa S; Nakano S; Wu J; Sakaguchi S; Takayanagi M; Sasaki KI; Satoh S
    J Pharm Pharmacol; 2001 Jul; 53(7):1029-39. PubMed ID: 11480538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of xanthine derivatives on the influx and efflux of doxorubicin in P388 and DOX-resistant P388 leukemia cells.
    Sadzuka Y; Egawa Y; Sawanishi H; Miyamoto K; Sonobe T
    Toxicol Lett; 2002 Sep; 135(1-2):137-44. PubMed ID: 12243872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced efficacy of 1-methyl-3-propyl-7-butylxanthine on the antitumor activity of doxorubicin against doxorubicin-resistant P388 leukemia.
    Sadzuka Y; Sugiyama T; Sawanishi H; Miyamoto K
    Cancer Lett; 1999 Apr; 138(1-2):5-11. PubMed ID: 10378767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cis-unsaturated fatty acids on doxorubicin sensitivity in P388/DOX resistant and P388 parental cell lines.
    Liu QY; Tan BK
    Life Sci; 2000; 67(10):1207-18. PubMed ID: 10954054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
    Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione and cellular resistance to anti-cancer drugs.
    Hedley D; Chow S
    Methods Cell Biol; 1994; 42 Pt B():31-44. PubMed ID: 7533246
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modulation of anthracycline resistance by reserpine in P388 leukemia cells].
    Shibata H; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
    Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):1-6. PubMed ID: 1889760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymes.
    Nair S; Singh SV; Samy TS; Krishan A
    Biochem Pharmacol; 1990 Feb; 39(4):723-8. PubMed ID: 2306280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Augmentation of pirarubicin cytotoxicity by chlorpromazine in doxorubicin-resistant mouse P388 leukemia cells].
    Shibata H; Sano F; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
    Yakugaku Zasshi; 1990 Sep; 110(9):678-81. PubMed ID: 2262880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
    Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of DMDP, a tiapamil analogue, on adriamycin efflux in adriamycin-resistant and -sensitive P388 cells.
    Radel S; Mayhew E; Rustum YM
    Anticancer Res; 1987; 7(6):1105-8. PubMed ID: 3442407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross resistance and cellular uptake of 4'-O-methyldoxorubicin in experimental tumors with acquired resistance to doxorubicin.
    Di Marco A; Skovsgaard T; Casazza AM; Pratesi G; Nissen NI; Danø K
    Cancer Chemother Pharmacol; 1981; 7(1):15-20. PubMed ID: 7340984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug retention, efflux, and resistance in tumor cells.
    Krishan A; Fitz CM; Andritsch I
    Cytometry; 1997 Dec; 29(4):279-85. PubMed ID: 9415409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic resistance and drug development.
    Shoemaker R; Wolpert-DeFilippes M; Plowman J; Abbott B; Venditti J; Trader M; Griswold D; Gerlach J; Ling V
    Prog Clin Biol Res; 1986; 223():143-9. PubMed ID: 3809196
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel anthracycline analogs.
    Grandi M; Pezzoni G; Ballinari D; Capolongo L; Suarato A; Bargiotti A; Faiardi D; Spreafico F
    Cancer Treat Rev; 1990 Sep; 17(2-3):133-8. PubMed ID: 2272029
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of the transport of novel nitrosoalkylurea derivative, nitrulline, into tumor and normal cells].
    Shulepova TS; Belousova AK
    Biull Eksp Biol Med; 1996 Dec; 122(12):648-50. PubMed ID: 9280464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.